Statement on NIH funding of research using gene-editing technologies in human embryos | National Institutes of Health (NIH)
Description
Researchers in China have recently described their experiments in a nonviable human embryo to modify the gene responsible for a potentially fatal blood disorder using a gene-editing technology called CRISPR/Cas9.